155 results
Page 5 of 8
DEF 14A
ubn3f20eg1ml
28 Oct 21
Definitive proxy
3:07pm
DEFA14A
wp1 thjn4ia1c
28 Oct 21
Additional proxy soliciting materials
2:54pm
8-K
EX-2.1
qxd490c p9pfpnbvafud
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
0scftuf51a pqv
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
ss98xta 14y
24 Sep 21
Annual report
7:31am
10-K
EX-31.1
jw9v5f
24 Sep 21
Annual report
7:31am
10-K
EX-10.10
v7sqybja2gckr8z8til
24 Sep 21
Annual report
7:31am
10-K
EX-31.2
5b5dfpi 756gddjq9
24 Sep 21
Annual report
7:31am
424B3
sk84mlxbi npztmb
22 Jul 21
Prospectus supplement
10:27am
UPLOAD
yn5jln7vp19mnij55
19 Jul 21
Letter from SEC
12:00am
8-K
EX-4.1
vc90n
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-4.2
i6z4ew1q2 xdsrp5o
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-10.1
keuvo
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-10.2
oboe69m
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am